1. Home
  2. IPDN vs BFRI Comparison

IPDN vs BFRI Comparison

Compare IPDN & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IPDN

Professional Diversity Network Inc.

HOLD

Current Price

$0.78

Market Cap

9.5M

Sector

Technology

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.08

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPDN
BFRI
Founded
2003
1997
Country
United States
United States
Employees
N/A
94
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
13.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
IPDN
BFRI
Price
$0.78
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
73.8K
110.3K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,054,219.00
N/A
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.54
52 Week High
$12.39
$1.18

Technical Indicators

Market Signals
Indicator
IPDN
BFRI
Relative Strength Index (RSI) 36.53 58.33
Support Level N/A $0.79
Resistance Level $1.02 $1.17
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.00
Stochastic Oscillator 28.72 47.06

Price Performance

Historical Comparison
IPDN
BFRI

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: